Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Hernández D et al. |
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. |
2007 |
Transplantation |
pmid:17893603
|
Khanafer A et al. |
Increased nitric oxide production during acute rejection in kidney transplantation: a useful marker to aid in the diagnosis of rejection. |
2007 |
Transplantation |
pmid:17876269
|
Benito N et al. |
Alternariosis after liver transplantation. |
2001 |
Transplantation |
pmid:11740399
|
Schäffer MR et al. |
Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. |
1998 |
Transplantation |
pmid:9539093
|
Kim CD et al. |
Metabonomic analysis of serum metabolites in kidney transplant recipients with cyclosporine A- or tacrolimus-based immunosuppression. |
2010 |
Transplantation |
pmid:20842074
|
Gathogo E et al. |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. |
2016 |
Transplantation |
pmid:26413990
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Demmers MW et al. |
Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells. |
2014 |
Transplantation |
pmid:24704664
|
Migita K et al. |
FK506 potentiates steroid-induced T-cell apoptosis. |
1997 |
Transplantation |
pmid:9371682
|
Manitpisitkul W et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. |
2009 |
Transplantation |
pmid:19584685
|
Fujimura Y and Owen RL |
Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches. |
2002 |
Transplantation |
pmid:11965030
|
Tanabe M et al. |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. |
1994 |
Transplantation |
pmid:7518619
|
Bozorgzadeh A et al. |
Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. |
2004 |
Transplantation |
pmid:15087773
|
Barraclough KA et al. |
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. |
2012 |
Transplantation |
pmid:23095803
|
Diem HV et al. |
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. |
2003 |
Transplantation |
pmid:12777858
|
Smets F et al. |
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. |
2002 |
Transplantation |
pmid:12042647
|
Heidt S et al. |
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. |
2008 |
Transplantation |
pmid:19005412
|
Serón D et al. |
Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. |
2007 |
Transplantation |
pmid:17353788
|
Vennarecci G et al. |
Apoptosis and rejection in rat intestinal transplantation: correlation with FK506 doses and donor specific bone marrow infusions. |
2001 |
Transplantation |
pmid:11455248
|
Imado T et al. |
Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect. |
2004 |
Transplantation |
pmid:14966413
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Araki M et al. |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. |
2006 |
Transplantation |
pmid:16477217
|
Schulman SL et al. |
Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. |
1998 |
Transplantation |
pmid:9625026
|
Hayashi S et al. |
Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation. |
2005 |
Transplantation |
pmid:16123724
|
Pacifico L et al. |
Tacrolimus and food allergy. |
2003 |
Transplantation |
pmid:14688538
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Glicklich D et al. |
Chronic renal allograft rejection: no response to mycophenolate mofetil. |
1998 |
Transplantation |
pmid:9721811
|
Ciancio G et al. |
Review of major clinical trials with mycophenolate mofetil in renal transplantation. |
2005 |
Transplantation |
pmid:16251852
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplantation |
pmid:12499885
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Mazariegos GV et al. |
Weaning of immunosuppression in liver transplant recipients. |
1997 |
Transplantation |
pmid:9020325
|
Marks WH et al. |
Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes. |
1997 |
Transplantation |
pmid:9020333
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
de Jonge H et al. |
Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation. |
2010 |
Transplantation |
pmid:20592652
|
Krähenbühl S et al. |
Serious interaction between mibefradil and tacrolimus. |
1998 |
Transplantation |
pmid:9808502
|
Shibasaki S et al. |
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway. |
2013 |
Transplantation |
pmid:23269193
|